Boc-NH-PEG3

CAS No. 139115-92-7

Boc-NH-PEG3( PROTAC Linker 10 )

Catalog No. M20918 CAS No. 139115-92-7

Boc-NH-PEG3 is a PEG derivative containing a hydroxyl group and Boc-protected amino group and is a PROTAC linker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Boc-NH-PEG3
  • Note
    Research use only, not for human use.
  • Brief Description
    Boc-NH-PEG3 is a PEG derivative containing a hydroxyl group and Boc-protected amino group and is a PROTAC linker.
  • Description
    Boc-NH-PEG3 is a PEG derivative containing a hydroxyl group and Boc-protected amino group and is a PROTAC linker.
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    PROTAC Linker 10
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PROTAC Linker
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    139115-92-7
  • Formula Weight
    249.3
  • Molecular Formula
    C11H23NO5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (401.12 mM)
  • SMILES
    CC(C)(C)OC(=O)NCCOCCOCCO
  • Chemical Name
    tert-butyl (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sainan An Liwu et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.[J]. EBioMedicine 2018.
molnova catalog
related products
  • A1874

    A1874 (A-1874) is a nutlin-based and BRD4-degrading PROTAC with DC50 of 32 nM (induce BRD4 degradation in cells).

  • Rpn13 degrader WL40

    Rpn13 degrader WL40 (WL40) is a novel covalent ubiquitin receptor Rpn13 degrader by linking the Rpn13 covalent inhibitor RA190 with the cereblon (CRBN) binding ligand thalidomide.

  • ARV-771

    ARV-771, a small-molecule pan-BET degrader based on proteolysis-targeting chimera (PROTAC) technology, demonstrates dramatically improved efficacy in cellular models of CRPC as compared with BET inhibition.